Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer

Get up to date on the latest data and expert guidance for optimal perioperative treatment of early-stage breast cancer with downloadable slides and an on-demand webcast capturing a live symposium at ASCO 2023. Then, download an infographic and read the accompanying expert commentary on individualizing therapy selection for your patients with early-stage breast cancer.

Share

Program Content

Activities

High-Risk HR+/HER2- EBC
Evaluating and Managing High-Risk Disease in HR+/HER2- EBC (Without gBRCA)
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2023

BRCA1/2 in HER2- EBC
Testing and Targeting BRCA1/2 in HER2- EBC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

Early TNBC
The New Treatment Paradigm and Ongoing Questions for Early-Stage TNBC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

Activities

Early-Stage Breast Cancer
Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 19, 2023

Expires: June 18, 2024

Activities

EBC FAQs
The Evolving Treatment of Early Breast Cancer: Expert Answers to FAQs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2023

Activities

Neo/Adj Tx for HER2- EBC
Key Decision Points in Neoadjuvant and Adjuvant Treatment Selection for Early-Stage HER2-Negative Breast Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC